|
Volumn 38, Issue 1, 2002, Pages 96-102
|
Plasmablastic lymphoma: An HIV-associated entity with primary oral manifestations
|
Author keywords
AIDS; CD38; EBV; HIV; Lymphoma; Oral; Plasmablastic
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD20 ANTIGEN;
CD3 ANTIGEN;
CD4 ANTIGEN;
CD45 ANTIGEN;
CD56 ANTIGEN;
CD79A ANTIGEN;
CISPLATIN;
CYTARABINE;
DOXORUBICIN;
DOXORUBICIN DERIVATIVE;
EFAVIRENZ;
EPITHELIAL MEMBRANE ANTIGEN;
ETOPOSIDE;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN KAPPA CHAIN;
IMMUNOGLOBULIN LAMBDA CHAIN;
LATENT MEMBRANE PROTEIN 1;
PROTEIN P63;
RITONAVIR;
SAQUINAVIR;
UNCLASSIFIED DRUG;
VIRUS DNA;
VIRUS RNA;
ADULT;
ANTIGEN EXPRESSION;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CASE REPORT;
CLINICAL FEATURE;
DIFFERENTIAL DIAGNOSIS;
EPSTEIN BARR VIRUS;
GENE AMPLIFICATION;
HISTOPATHOLOGY;
HUMAN;
HUMAN HERPESVIRUS 8;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNOHISTOCHEMISTRY;
IN SITU HYBRIDIZATION;
KAPOSI SARCOMA;
LYMPHOMA;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
MOUTH CARCINOMA;
PLASMABLASTIC LYMPHOMA;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
TUMOR BIOPSY;
TUMOR CELL;
VIRUS DETECTION;
VIRUS LOAD;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
DIAGNOSIS, DIFFERENTIAL;
EPSTEIN-BARR VIRUS INFECTIONS;
FATAL OUTCOME;
HIV INFECTIONS;
HUMANS;
LYMPHOMA, AIDS-RELATED;
MALE;
MIDDLE AGED;
MOUTH NEOPLASMS;
NEOPLASMS, SECOND PRIMARY;
SARCOMA, KAPOSI;
|
EID: 0036147046
PISSN: 13688375
EISSN: None
Source Type: Journal
DOI: 10.1016/S1368-8375(01)00018-5 Document Type: Article |
Times cited : (100)
|
References (30)
|